As of 11:22am ET
| +0.01 / +0.70%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +389.51% increase from the last price of 1.43.
The current consensus among 1 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.